Therapeutic potency of oncolytic virotherapy-induced cancer stem cells targeting in brain tumors, current status, and perspectives

J Cell Biochem. 2019 Mar;120(3):2766-2773. doi: 10.1002/jcb.27661. Epub 2018 Oct 15.

Abstract

Brain tumors are the most common form of solid tumors in children and is presently a serious therapeutic challenge worldwide. Traditional treatment with chemotherapy and radiotherapy was shown to be unsuccessful in targeting brain tumor cancer stem cells (CSCs), leading to recurrent, treatment-resistant secondary malignancies. Oncolytic virotherapy (OV) is an effective antitumor therapeutic strategy which offers a novel, targeted approach for eradicating pediatric brain tumor CSCs by utilizing mechanisms of cell killing that differ from conventional therapies. A number of studies and some clinical trials have therefore investigated the effects of combined therapy of radiations or chemotherapies with oncolytic viruses which provide new insights regarding the effectiveness and improvement of treatment responses for brain cancer patients. This review summarizes the current knowledge of the therapeutic potency of OVs-induced CSCs targeting in the treatment of brain tumors for a better understanding and hence a better management of this disease.

Keywords: brain tumor; cancer stem cell (CSC); oncolytic virotherapy (OV).

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Brain Neoplasms / pathology*
  • Brain Neoplasms / therapy*
  • Humans
  • Molecular Targeted Therapy*
  • Neoplastic Stem Cells / pathology*
  • Oncolytic Virotherapy / trends*
  • Oncolytic Viruses